Skip to content

Effect of Transcutaneous Auricular Vagus Nerve Stimulation Combined with Patient-Controlled Intravenous Analgesia on Postoperative Pain and Mood in Patients Undergoing Colorectal Cancer Surgery

Effect of Transcutaneous Auricular Vagus Nerve Stimulation Combined with Patient-Controlled Intravenous Analgesia on Postoperative Pain and Mood in Patients Undergoing Colorectal Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122460
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Control group:Sham transcutaneous auricular vagus nerve stimulation combined with patient-controlled intravenous analgesia
Experimental group:Transcutaneous Auricular Vagus Nerve Stimulation Combined with Patient-Controlled Intravenous Analgesia

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.ASA physical status classification Class I-III; 2.Age >=18 years old; 3.Patients scheduled for elective laparoscopic colorectal cancer surgery.

Exclusion criteria

Exclusion criteria: 1.Refusal to sign the informed consent form. 2.Patients who decline postoperative patient-controlled intravenous analgesia (PCIA). 3.Preoperative history of documented neurological or psychiatric disorders. 4.Individuals on long-term psychotropic medication for depression, anxiety, or sleep disorders. 5.Individuals with a history of chronic pain or long-term use of analgesics. 6.Abnormality at the ear stimulation site; 7.Concurrent use of other electrical stimulation devices (e.g., cardiac pacemakers). 8.Concomitant presence of severe respiratory diseases, severe cardiovascular or cerebrovascular diseases, severe hepatic insufficiency, or severe renal insufficiency. 9.Previous colorectal surgery; 10.Concurrent participation in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Area under the curve (AUC) of visual analog scale pain scores within 48 hours postoperatively;

Secondary

MeasureTime frame
Incidence of postoperative adverse events;Visual Analog Scale (VAS) pain scores on postoperative days 3 and 7;Anxiety, depression, and sleep scores on postoperative days 1, 3, and 7;Time to first passage of flatus postoperatively;NRL and CRP on postoperative days 1, 3, and 7;Recovery quality on postoperative day 7.;Number of patient-controlled analgesia (PCA) demands postoperatively;

Countries

China

Contacts

Public ContactShen Wen

The Affiliated Hospital of Xuzhou Medical University

Shenwen670201@163.com+86 13815311266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026